{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:19:03Z","timestamp":1789183143409,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bcp.2025.117182","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T16:49:35Z","timestamp":1752857375000},"page":"117182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Targeting BACH1\/PSPH axis suppresses bladder cancer progression and gemcitabine resistance by downregulating S100A2 expression"],"prefix":"10.1016","volume":"241","author":[{"given":"Tingxuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Kui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanchun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2025.117182_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2025.117182_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.bcp.2025.117182_b0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN guidelines(R) insights: bladder cancer, version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0020","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.urolonc.2020.10.006","article-title":"Systemic therapy in bladder preservation","volume":"41","author":"Girardi","year":"2023","journal-title":"Urol. Oncol."},{"issue":"19","key":"10.1016\/j.bcp.2025.117182_b0030","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bcp.2025.117182_b0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MOU.0000000000001177","article-title":"Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine","volume":"34","author":"Nossing","year":"2024","journal-title":"Curr. Opin. Urol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117182_b0040","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.7150\/ijbs.83774","article-title":"UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT","volume":"20","author":"Du","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117182_b0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.2001.4403","article-title":"Expression of l-3-phosphoserine phosphatase is regulated by reconstituted basement membrane","volume":"281","author":"Strunck","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2025.117182_b0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymgme.2009.10.012","article-title":"L-serine synthesis in the central nervous system: a review on serine deficiency disorders","volume":"99","author":"Tabatabaie","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7150\/ijbs.29203","article-title":"PSPH mediates the metastasis and proliferation of non-small cell lung cancer through MAPK signaling pathways","volume":"15","author":"Liao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2025.117182_b0060","first-page":"604","article-title":"Phosphoserine phosphatase promotes lung cancer progression through the dephosphorylation of IRS-1 and a noncanonical L-serine-independent pathway","volume":"42","author":"Park","year":"2019","journal-title":"Mol. Cells"},{"issue":"13","key":"10.1016\/j.bcp.2025.117182_b0065","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41388-021-01683-y","article-title":"PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1","volume":"40","author":"Rawat","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-02073-0","article-title":"Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117182_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005986","article-title":"Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy","volume":"11","author":"Peng","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupret","year":"2023","journal-title":"Eur. Urol."},{"issue":"2 Suppl 7","key":"10.1016\/j.bcp.2025.117182_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2001.24369","article-title":"Gemcitabine in advanced bladder cancer","volume":"28","author":"von der Maase","year":"2001","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bcp.2025.117182_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114650","article-title":"HOXB9 a miR-122-5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanoma","volume":"162","author":"Guo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117182_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116197","article-title":"KLF4 suppresses anticancer effects of brusatol via transcriptional upregulating NCK2 expression in melanoma","volume":"223","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117182_b0100","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s12276-024-01235-w","article-title":"The m(6)A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism","volume":"56","author":"Park","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117182_b0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/cr.2015.33","article-title":"cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions","volume":"25","author":"Sun","year":"2015","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117182_b0110","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.21873\/anticanres.11574","article-title":"Phosphoserine phosphatase is a novel prognostic biomarker on chromosome 7 in colorectal cancer","volume":"37","author":"Sato","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2025.117182_b0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fonc.2012.00065","article-title":"Analysis of PSPHL as a candidate gene influencing the racial disparity in endometrial cancer","volume":"2","author":"Allard","year":"2012","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12967-016-0915-8","article-title":"Expression of serine\/glycine metabolism-related proteins is different according to the thyroid cancer subtype","volume":"14","author":"Sun","year":"2016","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117182_b0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/1759-7714.13064","article-title":"Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients","volume":"10","author":"Liao","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.bcp.2025.117182_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145419","article-title":"Bone metastatic breast cancer cells display downregulation of PKC-zeta with enhanced glutamine metabolism","volume":"775","author":"Tandon","year":"2021","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.bcp.2025.117182_b0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10549-010-0848-5","article-title":"Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis","volume":"125","author":"Pollari","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.bcp.2025.117182_b0140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/0008-5472.CAN-20-1323","article-title":"Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism","volume":"81","author":"Cai","year":"2021","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.bcp.2025.117182_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8786","article-title":"Suppression of nuclear GSK3 signaling promotes serine\/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells","volume":"8","author":"He","year":"2022","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.bcp.2025.117182_b0150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbrc.2016.06.112","article-title":"Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer","volume":"477","author":"Li","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2025.117182_b0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s43018-024-00739-8","article-title":"Cycling back to folate metabolism in cancer","volume":"5","author":"Lee","year":"2024","journal-title":"Nature Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2025.117182_b0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jdermsci.2011.06.001","article-title":"L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis","volume":"63","author":"Bachelor","year":"2011","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117182_b0165","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1096\/fj.202000555R","article-title":"S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bcp.2025.117182_b0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41388-021-02116-6","article-title":"The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a novel therapeutic target for colorectal cancer metastasis","volume":"41","author":"Han","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/1078-0432.CCR-08-0953","article-title":"S100A2 induces metastasis in non-small cell lung cancer","volume":"15","author":"Bulk","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13048-024-01421-4","article-title":"NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells","volume":"17","author":"Liu","year":"2024","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41420-023-01661-1","article-title":"S100A2 induces epithelial-mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor beta signaling in SMAD4-dependent manner","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.bcp.2025.117182_b0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/0008-5472.CAN-22-3050","article-title":"Spatially resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intratumoral heterogeneity","volume":"83","author":"Williams","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117182_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109706","article-title":"ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction","volume":"36","author":"Li","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","article-title":"AMPK-HIF-1alpha signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth","volume":"42","author":"Yun","year":"2023","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"1","key":"10.1016\/j.bcp.2025.117182_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40364-024-00570-4","article-title":"Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy","volume":"12","author":"Hu","year":"2024","journal-title":"Biomarker Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117182_b0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","article-title":"BACH1 stabilization by antioxidants stimulates lung cancer metastasis","volume":"178","author":"Wiel","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2025.117182_b0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cell.2019.06.003","article-title":"Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1","volume":"178","author":"Lignitto","year":"2019","journal-title":"Cell"},{"issue":"7751","key":"10.1016\/j.bcp.2025.117182_b0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","article-title":"Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism","volume":"568","author":"Lee","year":"2019","journal-title":"Nature"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T13:26:55Z","timestamp":1767360415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S0006295225004472"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117182","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting BACH1\/PSPH axis suppresses bladder cancer progression and gemcitabine resistance by downregulating S100A2 expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117182"}}